Inhibikase Therapeutics, Inc. (IKT)
Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. DE
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 1 signal for Inhibikase Therapeutics, Inc.. Most notable: 2026-06-29: Filed 8-K disclosing director or officer change. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing director or officer change
- Insider purchaseSANDS FRANK M. (ten_percent_owner) bought $3.0M of stock
- Material 8-K filingFiled 8-K disclosing material agreement
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-30 | BERMAN DENNIS N | director | M | 21,854 | 1.26 | $27,536 |
| 2026-07-29 | RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Kolchinsky Peter; Shah Rajeev M. | ten percent owner | J | 18,030,000 | — | — |
| 2026-02-21 | Aurentz Vincent | director | D | 255,299 | 0 | $0 |
| 2026-02-21 | Cabell Christopher | officer | D | 338,282 | 0 | $0 |
| 2026-02-21 | Munshi Amit | director | D | 19,089 | 0 | $0 |
| 2026-02-21 | Aurentz Vincent | director | D | 255,299 | 0 | $0 |
| 2026-02-21 | Cabell Christopher | officer | D | 338,282 | 0 | $0 |
| 2026-02-21 | Munshi Amit | director | D | 19,089 | 0 | $0 |
| 2025-11-21 | SANDS FRANK M. | ten percent owner | P | 2,068,965 | 1.45 | $2,999,999 |
| 2025-11-21 | Sands Capital Life Sciences Pulse Fund II, L.P.; Sands Capital Alternatives, LLC; SANDS FRANK M. | ten percent owner | P | 2,068,965 | 1.45 | $2,999,999 |
| 2025-02-21 | Munshi Amit | director | A | 57,265 | 0 | $0 |
| 2025-02-21 | Munshi Amit | director | A | 57,265 | 0 | $0 |
| 2024-10-21 | Bellini Roberto | director | P | 1,460,000 | 1.37 | $2,000,200 |
| 2024-10-21 | Kush Arvind | director | P | 145,000 | 1.37 | $198,650 |
| 2024-10-21 | Munshi Amit | director | P | 365,000 | 1.37 | $500,050 |
| 2024-10-21 | Bellini Roberto | director | P | 1,460,000 | 1.37 | $2,000,200 |
| 2024-10-21 | Kush Arvind | director | P | 145,000 | 1.37 | $198,650 |
| 2024-10-21 | Munshi Amit | director | P | 365,000 | 1.37 | $500,050 |
| 2022-08-16 | Werner Milton H. | director | P | 5,000 | 0.8 | $4,000 |
| 2022-05-27 | Werner Milton H. | director | P | 5,000 | 0.98 | $4,880 |
| 2022-05-20 | Werner Milton H. | director | P | 10,000 | 0.6 | $6,000 |
| 2022-05-19 | FRATTAROLI JOSEPH | officer | P | 3,948 | 0.64 | $2,543 |
| 2022-01-03 | Werner Milton H. | director | M | 21,853 | 2.02 | $44,143 |
| 2021-11-17 | Werner Milton H. | director | P | 17,569 | 1.98 | $34,787 |
| 2021-11-17 | Werner Milton H. | director | P | 1,100 | 1.97 | $2,167 |
| 2021-11-17 | Werner Milton H. | director | P | 3,186 | 1.96 | $6,245 |
| 2021-11-17 | Werner Milton H. | director | P | 1,334 | 1.94 | $2,588 |
| 2021-11-17 | Werner Milton H. | director | P | 400 | 1.93 | $772 |
| 2021-08-17 | Werner Milton H. | director | M | 21,853 | 2.02 | $44,143 |
| 2021-05-14 | Werner Milton H. | director | M | 43,707 | 0.38 | $16,609 |
| 2021-05-14 | Werner Milton H. | director | F | 16,918 | 4.59 | $77,654 |
| 2020-12-28 | FRATTAROLI JOSEPH | officer | C | 44,143 | 10 | $441,430 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-09-08 8-K
- 2026-08-26 8-K
- 2026-08-14 SCHEDULE 13G/A
- 2026-08-14 SCHEDULE 13G/A
- 2026-08-13 SCHEDULE 13G/A
- 2026-08-11 S-8
- 2026-08-11 10-Q
- 2026-08-11 8-K
- 2026-07-31 SCHEDULE 13G/A
- 2026-07-31 4
- 2026-07-31 4
- 2026-07-29 8-K
- 2026-07-23 8-K
- 2026-07-17 3
- 2026-07-17 SCHEDULE 13G
- 2026-07-14 8-K
- 2026-06-30 4
- 2026-06-30 4
- 2026-06-30 4
- 2026-06-30 4